The results showed that PDLIM5 mRNA expression was upregulated in the PRAD group compared to the normal group, but PDLIM1/2/3/4/6/7 were downregulated in both unpaired (Figure 1(a)) and paired samples (Figure 1(b)). The gene discussed is PDLIM5; the disease is prostate adenocarcinoma.